ADO expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.127000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.509400E-01
Normal-vs-Stage2
4.184400E-01
Normal-vs-Stage3
1.242550E-01
Normal-vs-Stage4
5.127000E-01
Stage1-vs-Stage2
9.168800E-01
Stage1-vs-Stage3
2.896800E-01
Stage1-vs-Stage4
1.541600E-01
Stage2-vs-Stage3
1.975610E-01
Stage2-vs-Stage4
2.651800E-01
Stage3-vs-Stage4
1.115410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.486800E-01
Normal-vs-AfricanAmerican
8.173400E-01
Normal-vs-Asian
8.004600E-01
Caucasian-vs-AfricanAmerican
9.944400E-02
Caucasian-vs-Asian
1.780950E-01
AfricanAmerican-vs-Asian
5.364200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.830200E-01
Normal-vs-Female
4.684200E-01
Male-vs-Female
4.611800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.939800E-01
Normal-vs-Age(41-60Yrs)
7.854200E-01
Normal-vs-Age(61-80Yrs)
2.930800E-01
Normal-vs-Age(81-100Yrs)
1.107380E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.879800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.211600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.302000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.140900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.985600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.960000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.998150E-01
Normal-vs-Daily Drinker
1.161570E-01
Normal-vs-Weekly Drinker
7.963000E-01
Normal-vs-Occasional Drinker
6.959800E-01
Normal-vs-Social Drinker
4.590200E-01
Non Drinker-vs-Daily Drinker
5.462000E-01
Non Drinker-vs-Weekly Drinker
8.485700E-02
Non Drinker-vs-Occasional Drinker
1.231180E-01
Non Drinker-vs-Social Drinker
3.268600E-01
Daily Drinker-vs-Weekly Drinker
3.652200E-02
Daily Drinker-vs-Occasional Drinker
5.349800E-02
Daily Drinker-vs-Social Drinker
1.492830E-01
Weekly Drinker-vs-Occasional Drinker
8.139400E-01
Weekly Drinker-vs-Social Drinker
4.808800E-01
Occasional Drinker-vs-Social Drinker
6.303400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.118240E-01
Normal-vs-Grade 2
1.361740E-02
Normal-vs-Grade 3
3.763700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.973700E-02
Grade 1-vs-Grade 3
1.865990E-01
Grade 1-vs-Grade 4
1.118240E-01
Grade 2-vs-Grade 3
4.628000E-01
Grade 2-vs-Grade 4
1.361740E-02
Grade 3-vs-Grade 4
3.763700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.978750E-01
Normal-vs-NonDiabetic
3.816600E-01
Diabetic-vs-NonDiabetic
1.449840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.246400E-02
Normal-vs-NoPancreatitis
3.707000E-01
Pancreatitis-vs-NoPancreatitis
6.199600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.000400E-01
Normal-vs-N1
4.747400E-01
N0-vs-N1
4.902800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.516000E-01
Normal-vs-TP53-NonMutant
5.103800E-01
TP53-Mutant-vs-TP53-NonMutant
7.420800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
